LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Suchergebnis

Treffer 1 - 10 von insgesamt 120

Suchoptionen

  1. Buch: Landmarks in prostate cancer

    Boccon-Gibod, Laurent

    (BJU international ; 110, Suppl. 1 ; BJUI supplements)

    2012  

    Verfasserangabe guest ed.: Laurent Boccon-Gibod
    Serientitel BJU international ; 110, Suppl. 1
    BJUI supplements
    Überordnung
    Sprache Englisch
    Umfang 29 S.
    Verlag Wiley-Blackwell
    Erscheinungsort S.l.
    Erscheinungsland Vereinigtes Königreich
    Dokumenttyp Buch
    HBZ-ID HT017445452
    Datenquelle Katalog ZB MED Medizin, Gesundheit

    Zusatzmaterialien

    Kategorien

  2. Artikel: Legends in Urology.

    Boccon-Gibod, Laurent

    The Canadian journal of urology

    2019  Band 25, Heft 6, Seite(n) 9570–9572

    Mesh-Begriff(e) France ; History, 20th Century ; History, 21st Century ; Urethral Stricture/history ; Urethral Stricture/surgery ; Urology/history
    Sprache Englisch
    Erscheinungsdatum 2019-01-15
    Erscheinungsland Canada
    Dokumenttyp Autobiography ; Historical Article ; Journal Article ; Portrait
    ZDB-ID 2064475-9
    ISSN 1195-9479
    ISSN 1195-9479
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  3. Buch ; Konferenzbeitrag: Do alpha-blockers impact on the natural history of BPH?

    Boccon-Gibod, Laurent

    satellite symposium held during the XVth congress of the European Association of Urology, Brussels, Belgium, April 13, 2000 ; 4 tables

    (European urology ; 39, Suppl. 6)

    2001  

    Körperschaft European Association of Urology
    Verfasserangabe guest ed. Laurent Boccon-Gibod
    Serientitel European urology ; 39, Suppl. 6
    Überordnung
    Sprache Englisch
    Umfang 26 S. : Ill., graph. Darst.
    Verlag Karger
    Erscheinungsort Basel u.a.
    Erscheinungsland Schweiz
    Dokumenttyp Buch ; Konferenzbeitrag
    HBZ-ID HT012998902
    ISBN 3-8055-7233-6 ; 978-3-8055-7233-0
    Datenquelle Katalog ZB MED Medizin, Gesundheit

    Kategorien

  4. Buch: New avenues and perspectives in the management of advanced prostate cancer

    Boccon-Gibod, Laurent

    Paris, September 1, 1996 ; 10 tables

    (European urology ; 31, Suppl. 2)

    1997  

    Verfasserangabe guest ed. Laurent Boccon-Gibod
    Serientitel European urology ; 31, Suppl. 2
    Überordnung
    Schlagwörter Androgen Antagonists / therapeutic use / congresses ; Prostatic Neoplasms / drug therapy / congresses
    Sprache Englisch
    Umfang III, 39 S. : graph. Darst.
    Verlag Karger
    Erscheinungsort Basel u.a.
    Erscheinungsland Schweiz
    Dokumenttyp Buch
    HBZ-ID HT007462286
    ISBN 3-8055-6487-2 ; 978-3-8055-6487-8
    Datenquelle Katalog ZB MED Medizin, Gesundheit

    Kategorien

  5. Artikel ; Online: Rolf Ackermann (1941-2015): European urologist and gentleman.

    Boccon-Gibod, Laurent

    European urology

    2015  Band 67, Heft 6, Seite(n) 1198–1199

    Mesh-Begriff(e) History, 20th Century ; History, 21st Century ; Humans ; Male ; Physicians/history ; Prostatic Neoplasms/history ; Urology/history
    Sprache Englisch
    Erscheinungsdatum 2015-06
    Erscheinungsland Switzerland
    Dokumenttyp Biography ; Historical Article ; Journal Article
    ZDB-ID 193790-x
    ISSN 1873-7560 ; 1421-993X ; 0302-2838
    ISSN (online) 1873-7560 ; 1421-993X
    ISSN 0302-2838
    DOI 10.1016/j.eururo.2015.03.025
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  6. Artikel ; Online: Efficacy of lanadelumab in acquired angioedema with C1-inhibitor deficiency.

    Belbézier, Aude / Boccon-Gibod, Isabelle / Bouillet, Laurence

    The journal of allergy and clinical immunology. In practice

    2021  Band 9, Heft 6, Seite(n) 2490–2491

    Mesh-Begriff(e) Angioedema/drug therapy ; Angioedemas, Hereditary/drug therapy ; Antibodies, Monoclonal, Humanized ; Complement C1 Inactivator Proteins ; Complement C1 Inhibitor Protein/therapeutic use ; Humans
    Chemische Substanzen Antibodies, Monoclonal, Humanized ; Complement C1 Inactivator Proteins ; Complement C1 Inhibitor Protein ; lanadelumab (2372V1TKXK)
    Sprache Englisch
    Erscheinungsdatum 2021-02-06
    Erscheinungsland United States
    Dokumenttyp Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2843237-X
    ISSN 2213-2201 ; 2213-2198
    ISSN (online) 2213-2201
    ISSN 2213-2198
    DOI 10.1016/j.jaip.2021.01.040
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  7. Artikel ; Online: Efficacy of omalizumab for extracutaneous symptoms of chronic spontaneous urticaria.

    Belbezier, Aude / Boccon-Gibod, Isabelle / Bouillet, Laurence

    European journal of dermatology : EJD

    2021  Band 31, Heft 1, Seite(n) 86–87

    Mesh-Begriff(e) Adolescent ; Adult ; Aged ; Anti-Allergic Agents/therapeutic use ; Chronic Urticaria/diagnosis ; Chronic Urticaria/drug therapy ; Female ; Humans ; Male ; Middle Aged ; Omalizumab/therapeutic use ; Retrospective Studies ; Treatment Outcome ; Young Adult
    Chemische Substanzen Anti-Allergic Agents ; Omalizumab (2P471X1Z11)
    Sprache Englisch
    Erscheinungsdatum 2021-03-26
    Erscheinungsland France
    Dokumenttyp Letter
    ZDB-ID 1128666-0
    ISSN 1952-4013 ; 1167-1122
    ISSN (online) 1952-4013
    ISSN 1167-1122
    DOI 10.1684/ejd.2020.3717
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  8. Artikel ; Online: Profile of serious angioedema requiring an urgent advice from a national reference call center.

    Simon, Nicolas / Bocquet, Alexis / Boccon-Gibod, Isabelle / Bouillet, Laurence

    Medicine

    2022  Band 101, Heft 31, Seite(n) e29513

    Abstract: Angioedema (AE) is a reason for emergency care when it is severe. Care is difficult when the diagnostic is not known before the attack: mast cell (MC) or bradykinin (BK) mediated. One is very common but often benign, the other rare but potentially fatal. ...

    Abstract Angioedema (AE) is a reason for emergency care when it is severe. Care is difficult when the diagnostic is not known before the attack: mast cell (MC) or bradykinin (BK) mediated. One is very common but often benign, the other rare but potentially fatal. The French national reference center of angioedema (CREAK) provides emergency physicians with a hotline and a guideline to help them manage their patients. This study aimed to describe the clinical features of AE episodes prompting a call on the CREAK hotline and classify patients depending on the suspected cause of the AE. This is a retrospective study between March and August 2019. Each physician calling on the CREAK hotline was asked to fill a clinical description form for the AE emergency. Known patients of CREAK was excluded. Eighty four patients were included. Forty one (48.8%) in the angiotensin converting enzyme inhibitors induced acquired angioedema (ACEi-AAE), 39 (46.4%) in the mast cell induced angioedema, and 4 (4.8%) in the Bradykinin mediated angioedema. The mast cell induced angioedema patients have more history of hives (29.3%) than ACEi-AAE (2.4%, P = .0004). ACEi-AAE mainly affected the tongue (58.5% vs 25.6%, P = .003) and larynx (29.3% vs 13%, P = .001). In 65.5% of cases, the etiological diagnosis was not mentioned by the appellant, but made by the hotline. In 31% of cases, the hotline suggested the administration of a specific treatment not previously provided by the caller. All the doctors who called the hotline appreciate this tele-expertise especially in case of ACEi-AAE presumptions. In addition to providing rapid AE expertise, this service also allows to educate physicians in the management of AE irrespective of its origin.
    Mesh-Begriff(e) Angioedema/diagnosis ; Angioedema/etiology ; Angioedema/therapy ; Bradykinin/therapeutic use ; Call Centers ; Humans ; Retrospective Studies
    Chemische Substanzen Bradykinin (S8TIM42R2W)
    Sprache Englisch
    Erscheinungsdatum 2022-08-24
    Erscheinungsland United States
    Dokumenttyp Journal Article
    ZDB-ID 80184-7
    ISSN 1536-5964 ; 0025-7974
    ISSN (online) 1536-5964
    ISSN 0025-7974
    DOI 10.1097/MD.0000000000029513
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  9. Artikel ; Online: Effectiveness of lanadelumab in patients with hereditary angioedema with normal C1 inhibitor and FXII mutation.

    Bouillet, Laurence / Bocquet, Alexis / Belbezier, Aude / Boccon-Gibod, Isabelle

    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology

    2021  Band 127, Heft 3, Seite(n) 391–392

    Mesh-Begriff(e) Adult ; Angioedemas, Hereditary/drug therapy ; Angioedemas, Hereditary/genetics ; Antibodies, Monoclonal, Humanized/therapeutic use ; Complement C1 Inhibitor Protein/therapeutic use ; Factor XII/genetics ; Female ; Humans ; Middle Aged ; Mutation ; Treatment Outcome
    Chemische Substanzen Antibodies, Monoclonal, Humanized ; Complement C1 Inhibitor Protein ; lanadelumab (2372V1TKXK) ; Factor XII (9001-30-3)
    Sprache Englisch
    Erscheinungsdatum 2021-05-31
    Erscheinungsland United States
    Dokumenttyp Case Reports ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1228189-x
    ISSN 1534-4436 ; 0003-4738 ; 1081-1206
    ISSN (online) 1534-4436
    ISSN 0003-4738 ; 1081-1206
    DOI 10.1016/j.anai.2021.05.028
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  10. Buch: L'OPERE DES VOIES URINAIRES

    Boccon-Gibod, Laurent

    (SOINS EN CHIRURGIE)

    1982  

    Titelvarianten OPERE DES VOIES URINAIRES
    Verfasserangabe PAR LAURENT BOCCON-GIBOD
    Serientitel SOINS EN CHIRURGIE
    Schlagwörter URINARY TRACT / SURGERY
    Umfang VI, 80 S.
    Verlag MASSON
    Erscheinungsort PARIS (U.A.)
    Dokumenttyp Buch
    HBZ-ID HT002686769
    ISBN 2-225-75064-5 ; 978-2-225-75064-9
    Datenquelle Katalog ZB MED Medizin, Gesundheit

    Kategorien

Zum Seitenanfang